CORT Corcept Therapeutics

• $3.3M bought by 1 insider
• $7M sold by 5 insiders outside a trading plan
• $94.2M sold by 8 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. James N Wilson Director
   Planned sale
   $1.1M 10,000 shares at $114.81 0.9% of stake
   Traded Oct 15 Filed Oct 16
   ↗
3. Roberto Wandenkolk Vieira President, Oncology
   Planned sale
   $967K 8,333 shares at $116.10 68% of stake
   Traded Oct 2 Filed Oct 5
   ↗
4. Joseph Douglas Lyon See Remarks
   Planned sale
   $1.2M 10,000 shares at $116.07 64% of stake
   Traded Oct 1–2 Filed Oct 5
   ↗
5. Sean Maduck See Remarks
   Planned sale
   $2.9M 25,000 shares at $116.26 72% of stake
   Traded Oct 1–2 Filed Oct 5
   ↗
6. Roberto Wandenkolk Vieira President, Oncology
   Planned sale
   $30K 296 shares at $100.82 7% of stake
   Traded Sep 16 Filed Sep 18
   ↗
7. Joseph Douglas Lyon See Remarks
   Planned sale
   $1.1M 10,000 shares at $113.49 64% of stake
   Traded Sep 14 Filed Sep 16
   ↗
8. James N Wilson Director
   Planned sale
   $1.1M 10,000 shares at $110.69 0.9% of stake
   Traded Sep 15 Filed Sep 16
   ↗
9. Sean Maduck See Remarks
   Planned sale
   $2.9M 25,000 shares at $114.43 72% of stake
   Traded Sep 1 Filed Sep 3
   ↗
10. Roberto Wandenkolk Vieira President, Oncology
    Planned sale
    $6.5M 58,333 shares at $110.76 93% of stake
    Traded Sep 2 Filed Sep 3
    ↗
11. Kimberly Park Director
    Sale
    $3.3M 26,685 shares at $122.55 100% of stake
    Traded Aug 26 Filed Aug 28
    ↗
12. Sean Maduck See Remarks
    Planned sale
    $3.9M 30,955 shares at $125.58 76% of stake
    Traded Aug 25 Filed Aug 27
    ↗
13. David L Mahoney Director
    Planned sale
    $12.3M 103,606 shares at $118.25 8.4% of stake
    Traded Aug 18 Filed Aug 20
    ↗
14. Sean Maduck See Remarks
    Planned sale
    $419K 3,664 shares at $114.49 27% of stake
    Traded Aug 14 Filed Aug 18
    ↗
15. James N Wilson Director
    Planned sale
    $1.1M 10,000 shares at $111.43 0.9% of stake
    Traded Aug 14 Filed Aug 18
    ↗
16. Gary Charles Robb Chief Business Officer
    Sale
    $1.2M 10,000 shares at $116.26 20% of stake
    Traded Aug 17 Filed Aug 18
    ↗

Also filed in the last 12 months, not counted as buying or selling: 50 option exercises, 42 stock grants, 30 gifts, 23 share withholdings for taxes, and 9 other transactions.